After Stacey’s mom was diagnosed with breast cancer 8.5 years ago, Stacey’s doctors recommended that she start getting mammograms every year even though she wasn’t 40-years-old yet— the age when many women start to get mammograms.
During her annual mammogram in March 2018, a mass was found in her breast tissue. A biopsy confirmed it was cancer. As Stacey grappled with her diagnosis, she began discussing treatment options with her doctors.
It was decided that, in addition to surgery to remove the cancerous mass and radiation treatments, Stacey would take an oral medication for at least the next five to 10 years.
“As I was coming to terms with having to take a cancer medication for many years, my friend told me about the OneOme RightMed® test. She said it’s a genetic test that could help identify which medication may work best for me,” Stacey said. “I said that sounds amazing; I absolutely want to take it.”
“As I was coming to terms with having to take a cancer medication for many years, my friend told me about the OneOme RightMed® test.”
Stacey brought information about the RightMed test to her primary care doctor. Her doctor ordered it for Stacey, excited that the test covers hundreds of medications, including some that Stacey was already taking. Her doctor received Stacey’s results within days of sending her DNA sample to OneOme’s laboratory.
“When we got my RightMed test results back, my doctor and I saw that the breast cancer medication they were planning to prescribe me was marked yellow, meaning that a standard dose may not be most effective for me.”
After consulting with a pharmacist, Stacey’s oncologist decided that the medication they were originally going to prescribe Stacey — which is commonly prescribed for premenopausal women with breast cancer — may not be the most effective option for Stacey. Not only would Stacey need a much higher dose than what’s usually prescribed, but there’s also a predicted drug-drug interaction with the antidepressant she takes.
“The breast cancer medication they were planning to prescribe me was marked yellow, meaning that a standard dose may not be effective for me.”
Using information from the RightMed test as a guide, her oncologist selected a different medication that was in Stacey’s green category. When a medication is in the green category, it indicates the patient is more likely to process the medication at a normal rate, which may increase the chance that it will be effective at a standard dose and may reduce the risk of side effects.
“With the medication they chose, I have to receive injections to go into early menopause in order for it to be effective. But I have peace of mind knowing that the RightMed test helped my doctors find a better treatment option to prevent my cancer from coming back in the future.”
In addition to helping her doctors identify which breast cancer medication may work best for her, Stacey’s results confirmed that she likely processes the other medications she currently takes at a normal rate.
“It was reassuring to see the medications I currently take in my green category,” Stacey said.
Stacey now looks forward to having her test results on hand for the future. “I love that the RightMed test results are now in my patient file in case I need a new medication in the future. I will always make sure my doctors know about the results before they prescribe a medication.”
“I have peace of mind knowing that the RightMed test helped my doctors find a better treatment option to prevent my cancer from coming back.”
Looking back on her decision to get the RightMed test, Stacey said, “At the end of the day, I am grateful to have a caring friend that told me about a test that empowers me with information about my DNA. Now I don’t feel like I’m wasting time and money on a drug that may not work the way it should.”
Stacey wonders how her treatment would have been different had she not had information from the RightMed test. She also worries about others who may be on medications that aren’t best for them.
“We’re all different, we’re all made up differently. It only makes sense that we need different medications. I would encourage everybody to have this test.”